Enzymaster (Ningbo) Bio-Engineering Co.

BiotechnologySeries CNingbo, Chinaenzymaster.com

Latest round

Series C

Last raised

Jan 2022

Total raised

$24M

Investors

8

About Enzymaster (Ningbo) Bio-Engineering Co.

, Ltd. is a bio-catalysis solution provider that focuses on the development and commercialization of enzymatic and microbial catalysis technology., Ltd. The chairman Dr. Yongkai Huang has a PhD in medicinal chemistry from the National University of Singapore and more than 10 years of R&D experience in the bio-intelligence industry. He worked for Codexis. The company provides biocatalysts solution and enzyme catalytic technology. The company has built up a stockpile of many enzymes. At present, there are 15 pharmaceutical intermediates and food additives that have been commercialized. In addition, the company has involved in the fields of pesticides, veterinary drugs, flavors and fragrances, materials and RNA synthesis. The company's main business is R&D, design, manufacturing and sales of various catalytic enzymes.

Who invested in Enzymaster (Ningbo) Bio-Engineering Co.

8 investors across 3 rounds

See all investors in Enzymaster (Ningbo) Bio-Engineering Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jan 24, 2022

    Amount

    $24M

    Investors

    Locked

  2. Series C

    Nov 26, 2021

    Amount

    Undisclosed

    Investors

    Locked

  3. Series A

    Mar 24, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Enzymaster (Ningbo) Bio-Engineering Co.

Who invested in Enzymaster (Ningbo) Bio-Engineering Co.?

Enzymaster (Ningbo) Bio-Engineering Co. has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Enzymaster (Ningbo) Bio-Engineering Co. raised?

Enzymaster (Ningbo) Bio-Engineering Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Enzymaster (Ningbo) Bio-Engineering Co. last raise money?

Enzymaster (Ningbo) Bio-Engineering Co.'s most recent round on record is a Series C, in Jan 2022.

What does Enzymaster (Ningbo) Bio-Engineering Co. do?

Enzymaster (Ningbo) Bio-Engineering Co. is a biotechnology company.

Where is Enzymaster (Ningbo) Bio-Engineering Co. headquartered?

Enzymaster (Ningbo) Bio-Engineering Co. is headquartered in Ningbo, China.

Which VCs invest in companies like Enzymaster (Ningbo) Bio-Engineering Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Enzymaster (Ningbo) Bio-Engineering Co.'s stage. Their profiles are linked below.

Raising like Enzymaster (Ningbo) Bio-Engineering Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.